Spondyloarthritis in the peripartum period: a systematic review of current knowledge and clinical implications. [PDF]
Gross N, Molto A, Felten R.
europepmc +1 more source
Identifying Flare Prone Spondyloarthritis: Insights From a Prospective Cohort. [PDF]
Krishnan V A +7 more
europepmc +1 more source
Real-world retention rate of secukinumab in patients with axial spondyloarthritis: Multi-centric retrospective data from China. [PDF]
Fu Z +9 more
europepmc +1 more source
Clinical characteristics, disease activity and psychosocial burden of axial spondyloarthritis in Jordan: a multicenter cross-sectional study. [PDF]
Alnaimat F +6 more
europepmc +1 more source
Phase II randomised, placebo-controlled study to evaluate the efficacy and safety of an MK2 inhibitor in ankylosing spondylitis. [PDF]
Maksymowych WP +12 more
europepmc +1 more source
Correction: Correlations among quality of life, spinal mobility, and disease activity in early-treated axial spondyloarthritis: a single-center cross-sectional study. [PDF]
Khampaen T +4 more
europepmc +1 more source
Receptor-Ligand Biomarker Profile in Ankylosing Spondylitis: Associations Between <i>AXL</i>/<i>MERTK</i> Expression, Circulating GAS6 and Protein S Levels, and Disease Activity. [PDF]
Dogan SC +6 more
europepmc +1 more source
Assessment of active and inactive sacroiliitis in axial spondyloarthritis using DCE-MRI and ZOOMit-DWI parameters: A prospective study. [PDF]
Zhu Q +6 more
europepmc +1 more source
Real-world clinical experience with upadacitinib in a cohort of Italian patients with axial spondyloarthritis. [PDF]
Ramonda R +24 more
europepmc +1 more source
Clinical efficacy of tofacitinib in active ankylosing spondylitis and dynamic changes in gut microbiota: an exploratory descriptive four-case series with 16S rRNA sequencing analysis. [PDF]
Wang L, Xie W, Li J, Chen J, Huang Y.
europepmc +1 more source

